KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Capital Expenditures: 2010-2025

Historic Capital Expenditures for Exact Sciences (EXAS) over the last 15 years, with Sep 2025 value amounting to $29.9 million.

  • Exact Sciences' Capital Expenditures rose 14.29% to $29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $139.7 million, marking a year-over-year increase of 3.81%. This contributed to the annual value of $136.0 million for FY2024, which is 9.50% up from last year.
  • Exact Sciences' Capital Expenditures amounted to $29.9 million in Q3 2025, which was down 29.39% from $42.3 million recorded in Q2 2025.
  • Exact Sciences' Capital Expenditures' 5-year high stood at $72.9 million during Q4 2022, with a 5-year trough of $18.3 million in Q3 2021.
  • Its 3-year average for Capital Expenditures is $33.1 million, with a median of $34.7 million in 2023.
  • Its Capital Expenditures has fluctuated over the past 5 years, first tumbled by 83.64% in 2021, then skyrocketed by 143.90% in 2022.
  • Exact Sciences' Capital Expenditures (Quarterly) stood at $59.4 million in 2021, then increased by 22.70% to $72.9 million in 2022, then tumbled by 52.08% to $34.9 million in 2023, then climbed by 3.99% to $36.3 million in 2024, then climbed by 14.29% to $29.9 million in 2025.
  • Its last three reported values are $29.9 million in Q3 2025, $42.3 million for Q2 2025, and $31.2 million during Q1 2025.